Press Releases

Current Articles | Categories | Search | Syndication

Articles from June 2011
27 June 2011  
Study Results Show Switching from the Tuberculin Skin Test (TST) to an Interferon Gamma Release Assay (IGRA) can Improve Healthcare Worker Test Adherence at a Lower Cost
By @ 15:48 :: 2463 Views

 Oxford, UK & Marlborough, MA; June 27, 2011 –
The interim findings of the SWITCH study, “Screening healthcare Workers with IGRA vs. TST: Impact on Costs and adHerence to testing”, were presented today at the Association of Professionals in Infection Control and Epidemiology (APIC) annual meeting by Dr. Edward Bernacki, M.D. MPH, Executive Director, Health, Safety and Environment, The Johns Hopkins Health System and University, and Director, Division of Occupational Medicine, Johns Hopkins University, School of Medicine, a principal investigator of the study. The study compared costs and adherence to testing when healthcare workers were screened for tuberculosis (TB) using the tuberculin skin test (TST) or an Interferon Gamma Release Assay (IGRA).

Read More

22 June 2011  
EMBARGOED: NICE encourages more research on new test for heart attacks
By @ 09:23 :: 2398 Views

The National Institute for Health and Clinical Excellence (NICE) today (22 June), publishes medical technology guidance on the use of a test to rule out myocardial infarction (heart attack) in patients who have acute chest pain. The conclusions highlight that the BRAHMS copeptin assay shows potential to reduce the time taken to rule out myocardial infarction when used alongside a current test. The guidance recommends that more research is needed on the impact of the BRAHMS copeptin assay in clinical practice, before it can be supported for routine adoption in the NHS. This recommendation does not mean that the NHS shouldn’t use the test but that they should help with the collection of the further evidence required for future NICE evaluation.

Read More

21 June 2011  
FREE EDUCATIONAL SEMINARS
By @ 09:56 :: 2706 Views

FREE EDUCATIONAL SEMINARS
Focus on Serology/Focus On Driving Efficiencies

Roche are delighted to invite you to participate in their forthcoming educational days to be held on 29 & 30 June 2011 in central London (close to London Victoria Station).

Read More

21 June 2011  
Thermo Fisher Scientific Focuses on Dengue and Q Fever in Latest Issue of
By @ 09:53 :: 2372 Views

Thermo Fisher Scientific Focuses on Dengue and Q Fever in Latest Issue of Oxoid Culture Journal

BASINGSTOKE, England (June 21, 2011) – Thermo Fisher Scientific, the world leader in serving science, today announced that the latest edition of Culture (Volume 32, No 1) is now available. The issue focuses on two important febrile diseases: dengue, one of the world’s deadliest mosquito-borne viral diseases, infecting approximately 50 million people in the tropical and subtropical regions each year, and Q fever, zoonotic illness caused by Coxiella burnetii that is normally rare, but recently caused a large outbreak in the Netherlands.

Read More

17 June 2011  
Randox exhibits at the only online exhibition, BioConference Live 2011
By @ 14:30 :: 2333 Views

Randox exhibits at the only online exhibition, BioConference Live 2011 (www.bioconferencelive.com)


Visit our virtual booth at BioConference Live and participate in a live web chat with our product specialists from 9am – 4:30pm EDT on both 15th and 16th June, to find out how we can revolutionise your laboratory.

Read More

13 June 2011  
Capturing E. coli for faster detection
By @ 14:09 :: 2281 Views

Capturing E. coli for faster detection

13 June 2011; Bury, UK:  With the rapid isolation and identification of verocytotoxigenic strains of Escherichia coli a high priority, Lab M’s Captivate™ immunomagnetic separation (IMS) technique allows part of the conventional enrichment to be omitted, helping labs achieve faster results. 

Read More

08 June 2011  
Thermo Fisher Scientific Increases Production of Screening Solutions in Response to E. coli Crisis in Europe
By @ 14:45 :: 2465 Views

Thermo Fisher Scientific Increases Production of Screening Solutions in Response to E. coli Crisis in Europe


BASINGSTOKE, England (June 07, 2011) – Thermo Fisher Scientific, the world leader in serving science, has responded to the E. coli O104 crisis in Europe by increasing production and distribution of its Brilliance™ ESBL Agar plate, a chromogenic screening plate for the detection of Extended Spectrum β-Lactamase-producing (ESBL) organisms, such as the outbreak strain, within 24 hours.

Read More

02 June 2011  
Tuberculosis Expert Joins Oxford Immunotec as Senior Scientific Advisor
By @ 11:28 :: 2481 Views

Tuberculosis Expert Joins Oxford Immunotec as Senior Scientific Advisor

Oxford Immunotec announces that Michael D. Iseman, MD, a world-renowned pulmonologist and
leading authority on tuberculosis disease has joined the company as Senior Scientific Advisor. In this role, Dr. Iseman will provide guidance to Oxford Immunotec and healthcare professionals in their efforts to improve the diagnosis of TB infection and eradicate tuberculosis in the United States.

Read More